Sarcoidosis, or Besnier-Boeck-Schaumann Disease: The Frank Billings Lecture.

JAMA. 117: 1321-1327Baughman RP Lower EE du Bois RM. Sarcoidosis. Lancet. 361: 1111-1118Patel MR Cawley PJ Heitner JF Klem I Parker MA Jaroudi WA et al.

Detection of myocardial damage in patients with sarcoidosis.

Circulation. 120: 1969-1977Kandolin R Lehtonen J Airaksinen J Vihinen T Miettinen H Ylitalo K et al.

Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study.

Circulation. 131: 624-632Yafasova A Fosbol EL Schou M Gustafsson F Rossing K Bundgaard H et al.

Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.

J Am Coll Cardiol. 76: 767-777Moller DR Rybicki BA Hamzeh NY Montgomery CG Chen ES Drake W et al.

Genetic, Immunologic, and Environmental Basis of Sarcoidosis.

Ann Am Thorac Soc. 14 (): S429-SS36Su R Nguyen ML Agarwal MR Kirby C Nguyen CP Ramstein J et al.

Interferon-inducible chemokines reflect severity and progression in sarcoidosis.

Respir Res. 14: 121Ramstein J Broos CE Simpson LJ Ansel KM Sun SA Ho ME et al.

IFN-gamma-Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 Cells.

Am J Respir Crit Care Med. 193: 1281-1291Liu Y Qiu L Wang Y Aimurola H Zhao Y Li S et al.

The Circulating Treg/Th17 Cell Ratio Is Correlated with Relapse and Treatment Response in Pulmonary Sarcoidosis Patients after Corticosteroid Withdrawal.

PLoS One. 11e0148207Naruse TK Matsuzawa Y Ota M Katsuyama Y Matsumori A Hara M et al.

HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis.

Tissue Antigens. 56: 52-57Grunewald J Kaiser Y Ostadkarampour M Rivera NV Vezzi F Lotstedt B et al.

T-cell receptor-HLA-DRB1 associations suggest specific antigens in pulmonary sarcoidosis.

Eur Respir J. 47: 898-909Chen ES Wahlstrom J Song Z Willett MH Wiken M Yung RC et al.

T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

J Immunol. 181: 8784-8796Ostadkarampour M Eklund A Moller D Glader P Olgart Hoglund C Linden A et al.

Higher levels of interleukin IL-17 and antigen-specific IL-17 responses in pulmonary sarcoidosis patients with Lofgren's syndrome.

Clin Exp Immunol. 178: 342-352Wiken M Grunewald J Eklund A Wahlstrom J.

Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis.

J Clin Immunol. 29: 78-89Chen ES Song Z Willett MH Heine S Yung RC Liu MC et al.

Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

Am J Respir Crit Care Med. 181: 360-373Gabrilovich MI Walrath J van Lunteren J Nethery D Seifu M Kern JA et al.

Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis.

Clin Exp Immunol. 173: 512-522Stanton LA Fenhalls G Lucas A Gough P Greaves DR Mahoney JA et al.

Immunophenotyping of macrophages in human pulmonary tuberculosis and sarcoidosis.

Int J Exp Pathol. 84: 289-304Prokop S Heppner FL Goebel HH Stenzel W.

M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis.

Am J Pathol. 178: 1279-1286Li K Xu W Guo Q Jiang Z Wang P Yue Y et al.

Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.

Circ Res. 105: 353-364Heymans S Eriksson U Lehtonen J Cooper Jr., LT

The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy.

J Am Coll Cardiol. 68: 2348-2364Cozier YC Berman JS Palmer JR Boggs DA Serlin DM Rosenberg L.

Sarcoidosis in black women in the United States: data from the Black Women's Health Study.

Chest. 139: 144-150Rybicki BA Iannuzzi MC Frederick MM Thompson BW Rossman MD Bresnitz EA et al.

Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).

Am J Respir Crit Care Med. 164: 2085-2091Dumas O Abramovitz L Wiley AS Cozier YC Camargo Jr., CA

Epidemiology of Sarcoidosis in a Prospective Cohort Study of U.S.

Women. Ann Am Thorac Soc. 13: 67-71Morimoto T Azuma A Abe S Usuki J Kudoh S Sugisaki K et al.

Epidemiology of sarcoidosis in Japan.

Eur Respir J. 31: 372-379Martusewicz-Boros MM Boros PW Wiatr E Kempisty A Piotrowska-Kownacka D Roszkowski-Sliz K.

Cardiac Sarcoidosis: Is it More Common in Men?.

Lung. 194: 61-66Fussner LA Karlstedt E Hodge DO Fine NM Kalra S Carmona EM et al.

Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres.

Eur J Heart Fail. 20: 1713-1720Ning N Guo HH Iagaru A Mittra E Fowler M Witteles R.

Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis.

J Card Fail. 25: 307-311Roberts WC McAllister Jr., HA Ferrans VJ

Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11).

Am J Med. 63: 86-108Birnie DH Nery PB Ha AC Sarcoidosis Beanlands RS.Cardiac J Am Coll Cardiol. 68: 411-421Hulten E Agarwal V Cahill M Cole G Vita T Parrish S et al.

Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.

Circ Cardiovasc Imaging. 9e005001Birnie DH Sauer WH Bogun F Cooper JM Culver DA Duvernoy CS et al.

HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.

Heart Rhythm. 11: 1305-1323Ekstrom K Lehtonen J Nordenswan HK Mayranpaa MI Raisanen-Sokolowski A Kandolin R et al.

Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries.

Eur Heart J. 40: 3121-3128Nery PB Mc Ardle BA Redpath CJ Leung E Lemery R Dekemp R et al.

Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia.

Pacing Clin Electrophysiol. 37: 364-374Roberts WC Vowels TJ Ko JM Capehart JE Hall SA.

Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure.

Am J Cardiol. 103: 110-114Hiraga H Yuwai K Hiroe M.

Diagnostic standard and guidelines for sarcoidosis.

Jpn J Sarcoidosis Granulomatous Disord. 27: 102

New Guidelines for Diagnosis of Cardiac Sarcoidosis in Japan.

Annals of Nuclear Cardiology. 3: 42-45Judson MA Costabel U Drent M Wells A Maier L Koth L et al.

The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.

Sarcoidosis Vasc Diffuse Lung Dis. 31: 19-27Ribeiro Neto ML Jellis C Hachamovitch R Wimer A Highland KB Sahoo D et al.

Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: Is it time to regroup?.

Am Heart J. 223: 106-109Ueberham L Jahnke C Paetsch I Klingel K Kuehl M Hindricks G et al.

Current Diagnostic Criteria Show a Substantial Disagreement in Classification of Patients With Suspected Cardiac Sarcoidosis.

JACC Clin Electrophysiol. 7: 538-539Trivieri MG Spagnolo P Birnie D Liu P Drake W Kovacic JC et al.

Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.

J Am Coll Cardiol. 76: 1878-1901Rosenfeld LE Chung MK Harding CV Spagnolo P Grunewald J Appelbaum J et al.

Arrhythmias in Cardiac Sarcoidosis Bench to Bedside: A Case-Based Review.

Circ Arrhythm Electrophysiol. 14e009203Burstow DJ Tajik AJ Bailey KR DeRemee RA Taliercio CP.

Two-dimensional echocardiographic findings in systemic sarcoidosis.

Am J Cardiol. 63: 478-482Hulten E Aslam S Osborne M Abbasi S Bittencourt MS Blankstein R.

Cardiac sarcoidosis-state of the art review.

Cardiovasc Diagn Ther. 6: 50-63Agarwal A Sulemanjee NZ Cheema O Downey FX Tajik AJ.

Cardiac sarcoid: a chameleon masquerading as hypertrophic cardiomyopathy and dilated cardiomyopathy in the same patient.

Echocardiography. 31: E138-E141Mehta D Lubitz SA Frankel Z Wisnivesky JP Einstein AJ Goldman M et al.

Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing.

Chest. 133: 1426-1435Joyce E Ninaber MK Katsanos S Debonnaire P Kamperidis V Bax JJ et al.

Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis.

Eur J Heart Fail. 17: 51-62

Evaluation of Known or Suspected Cardiac Sarcoidosis.

Circ Cardiovasc Imaging. 9e000867

Document reading g, for ERTdwrbmotESDC. A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.

Eur Heart J Cardiovasc Imaging. 18: 1073-1089Shimada T Shimada K Sakane T Ochiai K Tsukihashi H Fukui M et al.

Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging.

Am J Med. 110: 520-527Smedema JP Snoep G van Kroonenburgh MP van Geuns RJ Dassen WR Gorgels AP et al.

Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.

J Am Coll Cardiol. 45: 1683-1690Kouranos V Tzelepis GE Rapti A Mavrogeni S Aggeli K Douskou M et al.

Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.

JACC Cardiovasc Imaging. 10: 1437-1447Greulich S Deluigi CC Gloekler S Wahl A Zurn C Kramer U et al.

CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.

JACC Cardiovasc Imaging. 6: 501-511Chareonthaitawee P Beanlands RS Chen W Dorbala S Miller EJ Murthy VL et al.

Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

J Nucl Cardiol. 24: 1741-1758Youssef G Leung E Mylonas I Nery P Williams K Wisenberg G et al.

The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience.

J Nucl Med. 53: 241-248Blankstein R Osborne M Naya M Waller A Kim CK Murthy VL et al.

Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

J Am Coll Cardiol. 63: 329-336Ahmadian A Brogan A Berman J Sverdlov AL Mercier G Mazzini M et al.

Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.

J Nucl Cardiol. 21: 925-939Vita T Okada DR Veillet-Chowdhury M Bravo PE Mullins E Hulten E et al.

Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac Sarcoidosis.

Circ Cardiovasc Imaging. 11e007030Cooper LT Baughman KL Feldman AM Frustaci A Jessup M Kuhl U et al.

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology.

Circulation. 116: 2216-2233Uemura A Morimoto S Hiramitsu S Kato Y Ito T Hishida H.

Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies.

Am Heart J. 138 (): 299-302Liang JJ Hebl VB DeSimone CV Madhavan M Nanda S Kapa S et al.

Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis.

JACC Heart Fail. 2: 466-473Ardehali H Howard DL Hariri A Qasim A Hare JM Baughman KL et al.

A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy.

Am Heart J. 150: 459-463Murtagh G Laffin LJ Beshai JF Maffessanti F Bonham CA Patel AV et al.

Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.

Circ Cardiovasc Imaging. 9e003738Juneau D Nery P Russo J de Kemp RA Leung E Beanlands RSB et al.

How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body (18)F-fluorodeoxyglucose positron emission tomography.

Int J Cardiol. 253: 189-193Okada DR Bravo PE Vita T Agarwal V Osborne MT Taqueti VR et al.

Isolated cardiac sarcoidosis: A focused review of an under-recognized entity.

J Nucl Cardiol. 25: 1136-1146Rosenbaum AN Kolluri N Elwazir MY Kapa S Abou Ezzeddine OF Bois JP et al.

Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of disease.

Int J Cardiol. Smith ED Lakdawala NK Papoutsidakis N Aubert G Mazzanti A McCanta AC et al.

Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.

Circulation. 141: 1872-1884Kransdorf EP Fishbein MC Czer LS Patel JK Velleca A Tazelaar HD et al.

Pathology of Chronic Chagas Cardiomyopathy in the United States: A Detailed Review of 13 Cardiectomy Cases.

Am J Clin Pathol. 146: 191-198Vasaiwala SC Finn C Delpriore J Leya F Gagermeier J Akar JG et al.

Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia.

J Cardiovasc Electrophysiol. 20: 473-476Philips B Madhavan S James CA te Riele AS Murray B Tichnell C et al.

Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear.

Circ Arrhythm Electrophysiol. 7: 230-236Asimaki A Tandri H Duffy ER Winterfield JR Mackey-Bojack S Picken MM et al.

Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.

Circ Arrhythm Electrophysiol. 4: 743-752Haley R Crimm H Hulten E Huffer L Flanagan MC.

Cardiac sarcoidosis presenting as hypertrophic cardiomyopathy.

Eur Heart J. 38: 2377Yancy CW Jessup M Bozkurt B Butler J Casey Jr, DE Drazner MH et al.

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Circulation. 128: 1810-1852

Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach.

Clin Med Insights Cardiol. 8 (): 31-37Pelliccia A Solberg EE Papadakis M Adami PE Biffi A Caselli S et al.

Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC).

Eur Heart J. 40: 19-33Bozkurt B Fonarow GC Goldberg LR Guglin M Josephson RA Forman DE et al.

Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.

J Am Coll Cardiol. 77: 1454-1469Banba K Kusano KF Nakamura K Morita H Ogawa A Ohtsuka F et al.

Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis.

Heart Rhythm. 4: 1292-1299Okada DR Smith J Derakhshan A Gowani Z Misra S Berger RD et al.

Ventricular Arrhythmias in Cardiac Sarcoidosis.

Circulation. 138: 1253-1264Yatsynovich Y Valencia D Petrov M Linares JD Rahman MM Dittoe N.

Updates on the Role of Imaging in Cardiac Sarcoidosis.

Curr Treat Options Cardiovasc Med. 20: 74Yalagudri S Zin Thu N Devidutta S Saggu D Thachil A Chennapragada S et al.

Tailored approach for management of ventricular tachycardia in cardiac sarcoidosis.

J Cardiovasc Electrophysiol. 28: 893-902Papageorgiou N Providencia R Bronis K Dechering DG Srinivasan N Eckardt L et al.

Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review.

Europace. 20: 682-691Okada DR Assis FR Gilotra NA Ha JS Berger RD Calkins H et al.

Cardiac sympathectomy for refractory ventricular arrhythmias in cardiac sarcoidosis.

Heart Rhythm. 16: 1408-1413Rosenthal DG Cheng RK Petek BJ Masri SC Mikacenic C Raghu G et al.

Risk of Adverse Cardiovascular Events in Cardiac Sarcoidosis Independent of Left Ventricular Function.

Am J Cardiol. 127: 142-148Coleman GC Shaw PW Balfour Jr., PC Gonzalez JA Kramer CM Patel AR et al.

Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis.

JACC Cardiovasc Imaging. 10: 411-420Gowani Z Habibi M Okada DR Smith J Derakhshan A Zimmerman SL et al.

Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.

Am J Cardiol. 134: 123-129Aizer A Stern EH Gomes JA Teirstein AS Eckart RE Mehta D.

Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.

Am J Cardiol. 96: 276-282Nordenswan HK Lehtonen J Ekström K Kandolin R Simonen P Mäyränpää M et al.

Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.

Circ Arrhythm Electrophysiol. 11e006145Patel D Trulock KM Toro S Grimaldi A Gonzalez M Moennich LA et al.

Effect of Cardiac Resynchronization Therapy on Left Ventricular Remodeling in Patients With Cardiac Sarcoidosis.

Am J Cardiol. 123: 329-333Cain MA Metzl MD Patel AR Addetia K Spencer KT Sweiss NJ et al.

Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias.

Am J Cardiol. 113: 1556-1560Habibi M Saad E Okada DR Berger RD Gilotra NA Tandri H et al.

Multimodality Imaging of Atrial Remodeling and Risk of Atrial Fibrillation in Patients With Cardiac Sarcoidosis.

JACC Cardiovasc Imaging. 14: 700-702Yazaki Y Isobe M Hiroe M Morimoto S-i Hiramitsu S Nakano T et al.

Prognostic Determinants of Long-Term Survival in Japanese Patients With Cardiac Sarcoidosis Treated With Prednisone.

Am J Cardiol. 88: 1006-1010Okada DR Saad E Wand AL Griffin JM Kasper EK Chen EH et al.

Effect of Corticosteroid Dose and Duration on 18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis.

JACC Cardiovasc Imaging. 13: 1280-1282Sadek MM Yung D Birnie DH Beanlands RS Nery PB.

Corticosteroid therapy for cardiac sarcoidosis: a systematic review.

Can J Cardiol. 29: 1034-1041Takaya Y Kusano KF Nakamura K Ito H.

Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis.

Am J Cardiol. 115: 505-509Nagai T Nagano N Sugano Y Asaumi Y Aiba T Kanzaki H et al.

Effect of Discontinuation of Prednisolone Therapy on Risk of Cardiac Mortality Associated With Worsening Left Ventricular Dysfunction in Cardiac Sarcoidosis.

Am J Cardiol. 117: 966-971Osborne MT Hulten EA Singh A Waller AH Bittencourt MS Stewart GC et al.

Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.

J Nucl Cardiol. 21: 166-174Segawa M Fukuda K Nakano M Kondo M Satake H Hirano M et al.

Time Course and Factors Correlating With Ventricular Tachyarrhythmias After Introduction of Steroid Therapy in Cardiac Sarcoidosis.

Circ Arrhythm Electrophysiol. 9Fillâtre P Decaux O Jouneau S Revest M Gacouin A Robert-Gangneux F et al.

Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative Patients.

Am J Med. 12 (): 1242Rosenthal DG Parwani P Murray TO Petek BJ Benn BS De Marco T et al.

Long-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.

J Am Heart Assoc. 8e010952Birnie D Beanlands RSB Nery P Aaron SD Culver DA DeKemp RA et al.

Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT).

American Heart Journal. 220: 246-252

Mechanisms of action of mycophenolate mofetil.

Lupus. 14 (): s2-s8Hamzeh N